Drug transporters in pharmacokinetics

Naunyn-Schmiedeberg's Archives of Pharmacology
E Petzinger, J Geyer

Abstract

This review deals with the drug transporters allowing drugs to enter and leave cells by carrier-mediated pathways. Emphasis is put on liver transporters but systems in gut, kidney, and blood-brain barrier are mentioned as well. Drug-drug interactions on carriers may provoke significant modification in pharmacokinetics as do carrier gene polymorphisms yielding functional carrier protein mutations. An integrated phase concept should reflect the interplay between drug metabolism and drug transport.

References

Jul 20, 1979·Naunyn-Schmiedeberg's Archives of Pharmacology·E PetzingerM Frimmer
Nov 11, 1976·Biochimica Et Biophysica Acta·R L Juliano, V Ling
Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·I B RoninsonI Pastan
Oct 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·W H HabigW B Jakoby
Jan 1, 1969·Annual Review of Physiology·J M Diamond, E M Wright
Jul 11, 1970·Nature·W J Ward
Apr 1, 1967·Experimental Eye Research·K Green
Jan 1, 1983·European Journal of Clinical Pharmacology·K E PedersenF Nielsen-Kudsk
Sep 4, 1981·Biochimica Et Biophysica Acta·E KrenningG Hennemann
Apr 1, 1980·British Journal of Clinical Pharmacology·R DahlqvistK Schenck-Gustafsson
Dec 1, 1995·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·E PetzingerA Hoffmann
Nov 21, 1993·Biochimica Et Biophysica Acta·K Ziegler, S Hummelsiep
Jan 4, 1994·Proceedings of the National Academy of Sciences of the United States of America·E JacqueminP J Meier
Oct 1, 1993·Physiological Reviews·J B Pritchard, D S Miller
May 1, 1993·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D K Meijer
Sep 1, 1996·European Journal of Clinical Investigation·W Kramer, G Wess
Jul 25, 1997·The Journal of Biological Chemistry·T SekineH Endou
Jun 1, 1997·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·C C Paulusma, R P Oude Elferink
Aug 1, 1997·FEMS Microbiology Reviews·H BolhuisW N Konings
Dec 31, 1997·The Journal of Biological Chemistry·D H SweetJ B Pritchard
Feb 21, 1998·Proceedings of the National Academy of Sciences of the United States of America·J M de VreeM Hadchouel
Feb 7, 1998·The Journal of Clinical Investigation·R B KimG R Wilkinson
Mar 26, 1998·Journal of Hepatology·M Müller, P L Jansen
Oct 22, 1998·The New England Journal of Medicine·M TraunerJ L Boyer
Mar 3, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D RostD Keppler
Mar 30, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J KönigD Keppler
Jul 20, 1999·The Journal of Clinical Investigation·B GreinerH K Kroemer
Oct 8, 1999·Clinical Pharmacology and Therapeutics·T Gramatté, R Oertel
Mar 4, 2000·Advanced Drug Delivery Reviews·J B Lloyd
Mar 11, 2000·American Journal of Physiology. Gastrointestinal and Liver Physiology·K OgawaY Sugiyama
Mar 23, 2000·Journal of Hepatology·G A Kullak-UblickG Paumgartner
Jun 3, 2000·American Journal of Physiology. Renal Physiology·G Burckhardt, N A Wolff
Apr 3, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C J SorokaJ L Boyer

❮ Previous
Next ❯

Citations

Mar 11, 2006·Naunyn-Schmiedeberg's Archives of Pharmacology·Ernst PetzingerRobert Tampé
Feb 19, 2008·Toxicological Sciences : an Official Journal of the Society of Toxicology·Manupat LohitnavyRaymond S H Yang
Jul 16, 2013·Amino Acids·Ahmed A Abdulhussein, Heather M Wallace
Nov 21, 2009·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Simona De GregoriMauro Stronati
Oct 4, 2006·Expert Opinion on Drug Metabolism & Toxicology·Stefano Persiani, Patrice Larger
Mar 29, 2014·Drug Metabolism Reviews·Ursula Gundert-RemyPeter H Roos
Aug 12, 2009·Expert Opinion on Drug Metabolism & Toxicology·Edmund Jon Deoon LeeLie Michael George Limenta
Apr 16, 2015·Expert Opinion on Drug Metabolism & Toxicology·Darren Michael MossMarco Siccardi
Dec 17, 2011·European Journal of Pharmacology·Bruno StiegerThomas van Gulik
Feb 24, 2009·Neuroscience·E H HagenP Hammerstein
Apr 25, 2007·Toxicon : Official Journal of the International Society on Toxinology·Takuya MatsumotoKazuo Shiomi
Nov 24, 2007·Fundamental & Clinical Pharmacology·Nathalie MaubonOlivier Fardel
Jun 19, 2010·Journal of Veterinary Pharmacology and Therapeutics·D ZahnerE Petzinger
Mar 9, 2011·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Cliff ChenA David Rodrigues
Nov 21, 2007·Protein Expression and Purification·William R TschantzMuhammed F Hashim
Aug 21, 2007·Biochimica Et Biophysica Acta·Olga GavrilovaErnst Petzinger
Feb 22, 2012·Chemistry and Physics of Lipids·Dominika WrobelMaria Bryszewska
May 28, 2019·Molecular Pharmacology·Vanessa MalagninoHenriette E Meyer Zu Schwabedissen
Aug 27, 2014·International Journal of Food Sciences and Nutrition·Kuo-Ching JanTristan C Liu
Dec 13, 2019·Drug Metabolism Reviews·Kodye L AbbottSatyanarayana R Pondugula
Feb 8, 2019·Nature Reviews. Nephrology·Sanjay K Nigam, Kevin T Bush
Sep 24, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Agnès PoirierChristoph Funk
Jan 29, 2021·Bioorganic & Medicinal Chemistry Letters·Shifan MaIstvan J Enyedy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood-Brain Barrier Transport in Neurodegeneration

The blood brain barrier is important for regulating the movement of biomolecules in and out of the brain. For example, membrane transporters in the blood brain barrier can be essential for regulating drug movement and dysregulation of these processes may play a role in neurodegeneration. This feed follows the latest research on this topic.

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.